| 摘要 |
The invention relates to a pharmaceutical composition for the treatment of ocular hypertension. The composition comprises an oculo-hypotensively synergistic combination of (a) a 13,14-dihydro-15-ketoprostaglandin compound, and (b) a cholinergic agent in association with a pharmaceutically acceptable carrier, diluent or excipient.
|
